Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01279031 · ClinicalTrials.gov registry record · Phase 4

Randomized Comparison of the Abbott WHITESTAR Signature System With Ellips Tranversal Ultrasound vs. the Alcon Infiniti With the Ozil Torsional Handpiece in Phacoemulsification: A Contralaterally-Controlled Trial

A Phase 4 study of Astigmatism and Cataracts, sponsored by Innovative Medical.

Completed
Registry status
Phase 4
Development phase
25
Enrollment target
1
Study location

NCT01279031 is a Phase 4 study of Astigmatism and Cataracts that has completed, run by Innovative Medical. The registered enrollment target is 25 participants, below the 105-participant average among 31 other Astigmatism trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01279031, a Phase 4 study of Astigmatism and Cataracts, has completed, sponsored by Innovative Medical.

COMPLETED
Registry status
Phase 4
Development phase
25 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to look at the outcomes of your vision after your cataract surgery based on two different types of equipment that will be used during your surgery.

Conditions Studied

Interventions

  • DEVICE Abbott WHITESTAR Signature System with Ellips Transversal Ultrasound
  • DEVICE Alcon Infiniti wiht the OZIL Torsional Handpiece

Study Locations (1)

California

  • Kerry Assil - Beverly Hills

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2011-10
Est. Completion 2012-01
Phase Phase 4

Sponsor

Innovative Medical

44 total trials

What the Registry Record Tells You About NCT01279031

The ClinicalTrials.gov registry entry for NCT01279031 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 105-participant average among 31 other Astigmatism trials with a reported enrollment target (76% lower). The listed sponsor is Innovative Medical, which has 44 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Astigmatism appearing as the primary indexed condition, and to 2 interventions - of which Abbott WHITESTAR Signature System with Ellips Transversal Ultrasound is the first listed.

NCT01279031 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT01279031 about?

NCT01279031 is a clinical study titled "Randomized Comparison of the Abbott WHITESTAR Signature System With Ellips Tranversal Ultrasound vs. the Alcon Infiniti With the Ozil Torsional Handpiece in Phacoemulsification: A Contralaterally-Controlled Trial". The purpose of this study is to look at the outcomes of your vision after your cataract surgery based on two different types of equipment that will be used during your surgery.

What is the current status of trial NCT01279031?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 25 participants. The study started on 2011-10. Estimated completion is 2012-01.

What conditions does trial NCT01279031 study?

This clinical trial studies the following conditions: Astigmatism, Cataracts.

What interventions are being tested in trial NCT01279031?

The interventions under investigation include: Abbott WHITESTAR Signature System with Ellips Transversal Ultrasound (DEVICE), Alcon Infiniti wiht the OZIL Torsional Handpiece (DEVICE).

Who is sponsoring clinical trial NCT01279031?

This trial is sponsored by Innovative Medical, which has 44 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01279031 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Astigmatism

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.